European Journal of Medicinal Chemistry p. 921 - 928 (1991)
Update date:2022-08-03
Topics:
Jukic
Mayer
Schmitt
Drapeau
Regoli
Michelot
A series of pseudopeptides, analogues of neurokinin selective agonists, in which a peptide bond was replaced by a (CH2NH) bond were synthesized. The biological activities of these compounds were determined on selective pharmacological preparations: the dog carotid artery for NK-1, the rabbit pulmonary artery devoid of endothelium for the NK-2 and the rat portal vein for the NK-3 receptors. The results reported in this study indicate that insertion of a pseudopeptide bond in various positions of these selective agonists resulted in a great decrease in potency compared to the parent compounds. Furthermore, the selectivity of agonists is maintained by the use of a methylene amino group in position 9-10 (Sar) for the NK-1 or in position 7-8 (MePhe) for the NK-3 selective compound. The selectivity is greatly diminished for the NK-2 analogues.
View MoreUK SHAREPOINT INTERNATIONAL TRADE CO., LTD(expird)
Contact:44-20-31299469
Address:FLAT 107 25 INDESCON SQUARE LONDON UNITED KINGDOM E14 9DG
website:http://www.chinabarton.com
Contact:+86-573-82719618
Address:No. 162 Fumin Road, Honghe Town,
PUYANG WANQUAN CHEMICAL CO.,LTD.
Contact:86-393-5388048
Address:Shihua Rd,Puyang city, Henan province, CN
Chengdu Pukang Biotechnology Co., Ltd
Contact:+86-28-82550498
Address:No. 558 Rulin Road,Xinjin county,Chengdu city, China
Reliable Pharma Technology (Shanghai) Co., Ltd.
Contact:0086-21-67676847-8008
Address:Lane 1500, No.68, Xinfei Road, Songjiang District, Shanghai, 201611, P.R.China.
Doi:10.1002/anie.201204287
(2012)Doi:10.1016/S0040-4039(00)92326-8
(1992)Doi:10.1016/j.tetlet.2004.12.102
(2005)Doi:10.1021/acs.jmedchem.5b01367
(2015)Doi:10.1021/ja307374j
(2012)Doi:10.1080/00397911.2013.869341
(2014)